cerrar
Tagged with Opinion

China’s National Reimbursement Drug List (NRDL) 2020: What…
Eric Bouteiller examines the most recent update to China’s National Reimbursement Drug List, the positive impact that a de facto annual review has…

Navigating the Increasingly Stormy Waters of US Market Access 
Certara's Ulrich Neumann examines some of the major US market access trends of the past few years, including the innovative financing models required…

Embryonic Gene Editing: How Far is Too Far to Find a Treatment…
Rare disease patient advocate Monica Weldon outlines some of the ethical conundrums around embryonic gene editing. With CRISPR technology again in the…

Securing Trust in the COVID-19 Supply Chain: From Development…
Scientists have come together in an unparalleled worldwide collaboration and sharing of data to advance a COVID-19 vaccine.[1] As rollouts become…

Five Trends for Life Science Companies to Watch in 2021
After a transformative 2020, Shawview Consulting’s Brendan Shaw looks into his crystal ball and makes five predictions (plus one) on the key trends…

Can Sweden take the lead in Precision Medicine?
Anders Blanck of Lif, the trade association for the research-based Swedish pharmaceutical industry, outlines the steps already being put in place for…

10 Key Insights from PharmaBoardroom Contributors in 2020
Although the COVID-19 pandemic and the subsequent rush to develop diagnostics, therapeutics, and vaccines dominated the global headlines in 2020,…

The Value Proposition of Generics & Biosimilars in the USA
AAM President Dan Leonard highlights the findings of the association’s most recent report and re-states the value proposition of generic and…

Why Europe Needs a Sustainable Pharma Manufacturing System
On 25 November, the European Commission adopted a new strategy meant to, among others, allow Europe to cover its pharmaceutical needs, including in…

Cross Country Collaborations in Europe: The Future of Pricing…
Merck VP for Global Market Access & Pricing Strategic Planning Marco Rauland examines the trend of collaboration between European countries…

Ethics in Artificial Intelligence: Better Prepare Now for New EU…
With upcoming EU regulation poised to have a massive impact on ethical regulations around AI in Europe, Bayer Head of Digital Transformation Saskia…

Is the USA’s Innovation Leadership Position At-Risk?
David H. Crean, managing director for Objective Capital Partners, provides insights on US innovation and long term sustainability. The…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here